23 related articles for article (PubMed ID: 9659887)
1. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.
Campbell RA; Overmyer KA; Selzman CH; Sheridan BC; Wolberg AS
Blood; 2009 Nov; 114(23):4886-96. PubMed ID: 19797520
[TBL] [Abstract][Full Text] [Related]
2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
3. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
Söderström T; Hedner U; Arnljots B
J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.
Lev EI; Marmur JD; Zdravkovic M; Osende JI; Robbins J; Delfin JA; Richard M; Erhardtsen E; Thomsen MS; Lincoff AM; Badimon JJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1036-41. PubMed ID: 12067917
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M
Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703
[TBL] [Abstract][Full Text] [Related]
6. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
7. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
Lee AY; Vlasuk GP
J Intern Med; 2003 Oct; 254(4):313-21. PubMed ID: 12974870
[TBL] [Abstract][Full Text] [Related]
8. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Hedner U; Erhardtsen E
Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
[TBL] [Abstract][Full Text] [Related]
10. rFVIIai in Acute Coronary Syndromes.
Sorensen BB; Hedner U; Erhardtsen E
Semin Vasc Med; 2003 May; 3(2):199-204. PubMed ID: 15199483
[TBL] [Abstract][Full Text] [Related]
11. Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.
Holst J; Kristensen AT; Kristensen HI; Ezban M; Hedner U
Eur J Vasc Endovasc Surg; 1998 Jun; 15(6):515-20. PubMed ID: 9659887
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
